Discrepancies and Interpretation Problems in Susceptibility Testing of VIM-1-Producing Klebsiella pneumoniae Isolates
暂无分享,去创建一个
V. Miriagou | G. Petrikkos | G. Daikos | A. Vatopoulos | L. Tzouvelekis | N. Legakis | P. Giakkoupi | P. Giakkoupi | L. S. Tzouvelekis | G. L. Daikos | V. Miriagou | G. Petrikkos | N. J. Legakis | A. C. Vatopoulos
[1] V. Miriagou,et al. Escherichia coli with a Self-Transferable, Multiresistant Plasmid Coding for Metallo-β-Lactamase VIM-1 , 2003, Antimicrobial Agents and Chemotherapy.
[2] Mary Jane Ferraro,et al. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .
[3] Clinical,et al. Performance standards for antimicrobial disk susceptibility tests : approved standard , 2006 .
[4] J. Wu,et al. Metallo-beta-lactamase-producing Enterobacteriaceae isolates in a university hospital in Taiwan: prevalence of IMP-8 in Enterobacter cloacae and first identification of VIM-2 in Citrobacter freundii. , 2002, The Journal of antimicrobial chemotherapy.
[5] Y. Tselentis,et al. Spread of blaVIM-1-producing e. coli in a university hospital in Greece. Genetic analysis of the integron carrying the blaVIM-1 metallo-β-lactamase gene , 2004 .
[6] R N Jones,et al. Multicenter laboratory evaluation of the bioMérieux Vitek antimicrobial susceptibility testing system with 11 antimicrobial agents versus members of the family Enterobacteriaceae and Pseudomonas aeruginosa , 1997, Journal of clinical microbiology.
[7] Yehuda Carmeli,et al. Failure of Quality Control Measures To Prevent Reporting of False Resistance to Imipenem, Resulting in a Pseudo-Outbreak of Imipenem-Resistant Pseudomonas aeruginosa , 1998, Journal of Clinical Microbiology.
[8] D. Yong,et al. A new integron carrying VIM-2 metallo-beta-lactamase gene cassette in a Serratia marcescens isolate. , 2002, Diagnostic microbiology and infectious disease.
[9] J. Waitz. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically , 1990 .
[10] V. Miriagou,et al. VIM-1 Metallo-β-Lactamase-Producing Klebsiella pneumoniae Strains in Greek Hospitals , 2003, Journal of Clinical Microbiology.
[11] V. Miriagou,et al. Imipenem Resistance in a Salmonella Clinical Strain Due to Plasmid-Mediated Class A Carbapenemase KPC-2 , 2003, Antimicrobial Agents and Chemotherapy.
[12] S. Jeong,et al. Characterization of a new integron containing VIM-2, a metallo- beta-lactamase gene cassette, in a clinical isolate of Enterobacter cloacae. , 2003, The Journal of antimicrobial chemotherapy.
[13] P. Nordmann,et al. Emerging carbapenemases in Gram-negative aerobes. , 2002, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[14] R. Gaynes,et al. Antimicrobial Susceptibility Testing of Carbapenems: Multicenter Validity Testing and Accuracy Levels of Five Antimicrobial Test Methods for Detecting Resistance in Enterobacteriaceae and Pseudomonas aeruginosa Isolates , 2003, Journal of Clinical Microbiology.
[15] J. Frère,et al. Purification and Biochemical Characterization of the VIM-1 Metallo-β-Lactamase , 2000, Antimicrobial Agents and Chemotherapy.